China Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read More
The labs at BryanLGH Medical Center save time and increase accuracy with the IG parameter from Sysmex.
Read MoreMolecularMD Corp announced that it has granted a sub-license agreement for the detection of ABL kinase mutations in Chronic Myelogenous Leukemia (CML) patients to the Mayo Clinic.
Read More
Systems add value beyond the digital image
Read MoreTesting of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine.
Read More